Compare Biocon with NEULAND LABS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs NEULAND LABS - Comparison Results

BIOCON      Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON NEULAND LABS BIOCON /
NEULAND LABS
 
P/E (TTM) x 34.4 69.4 49.5% View Chart
P/BV x 4.4 2.5 175.9% View Chart
Dividend Yield % 0.2 0.1 154.8%  

Financials

 BIOCON    NEULAND LABS
EQUITY SHARE DATA
    BIOCON
Mar-19
NEULAND LABS
Mar-20
BIOCON /
NEULAND LABS
5-Yr Chart
Click to enlarge
High Rs707754 93.9%   
Low Rs554247 223.9%   
Sales per share (Unadj.) Rs91.9594.5 15.5%  
Earnings per share (Unadj.) Rs16.712.6 132.3%  
Cash flow per share (Unadj.) Rs24.237.0 65.3%  
Dividends per share (Unadj.) Rs1.002.00 50.0%  
Dividend yield (eoy) %0.20.4 39.7%  
Book value per share (Unadj.) Rs101.6553.4 18.4%  
Shares outstanding (eoy) m600.0012.83 4,676.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.90.8 815.0%   
Avg P/E ratio x37.739.6 95.3%  
P/CF ratio (eoy) x26.113.5 192.9%  
Price / Book Value ratio x6.20.9 686.0%  
Dividend payout %6.015.8 37.8%   
Avg Mkt Cap Rs m378,3306,421 5,892.3%   
No. of employees `0006.11.3 478.2%   
Total wages/salary Rs m11,6531,236 943.1%   
Avg. sales/employee Rs Th8,994.35,949.4 151.2%   
Avg. wages/employee Rs Th1,900.7963.8 197.2%   
Avg. net profit/employee Rs Th1,635.3126.4 1,293.5%   
INCOME DATA
Net Sales Rs m55,1447,627 723.0%  
Other income Rs m1,44439 3,716.9%   
Total revenues Rs m56,5887,666 738.2%   
Gross profit Rs m15,8831,019 1,558.9%  
Depreciation Rs m4,478313 1,431.6%   
Interest Rs m709216 328.7%   
Profit before tax Rs m12,140529 2,294.0%   
Minority Interest Rs m90-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,123367 578.3%   
Profit after tax Rs m10,026162 6,185.8%  
Gross profit margin %28.813.4 215.6%  
Effective tax rate %17.569.4 25.2%   
Net profit margin %18.22.1 855.6%  
BALANCE SHEET DATA
Current assets Rs m48,2285,152 936.1%   
Current liabilities Rs m30,3763,576 849.4%   
Net working cap to sales %32.420.7 156.7%  
Current ratio x1.61.4 110.2%  
Inventory Days Days68105 65.0%  
Debtors Days Days8691 94.1%  
Net fixed assets Rs m64,1303,969 1,616.0%   
Share capital Rs m3,000129 2,325.6%   
"Free" reserves Rs m57,9806,971 831.8%   
Net worth Rs m60,9807,100 858.9%   
Long term debt Rs m15,766774 2,037.7%   
Total assets Rs m121,92412,310 990.5%  
Interest coverage x18.13.5 524.8%   
Debt to equity ratio x0.30.1 237.2%  
Sales to assets ratio x0.50.6 73.0%   
Return on assets %8.83.1 286.9%  
Return on equity %16.42.3 720.2%  
Return on capital %16.89.5 177.1%  
Exports to sales %28.10-   
Imports to sales %18.90-   
Exports (fob) Rs m15,506NA-   
Imports (cif) Rs m10,399NA-   
Fx inflow Rs m15,5065,187 299.0%   
Fx outflow Rs m10,3991,593 652.9%   
Net fx Rs m5,1073,594 142.1%   
CASH FLOW
From Operations Rs m11,546573 2,013.6%  
From Investments Rs m-7,138-487 1,466.3%  
From Financial Activity Rs m-2,417-55 4,410.6%  
Net Cashflow Rs m2,10333 6,450.9%  

Share Holding

Indian Promoters % 40.4 36.3 111.4%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 63.7 13.2%  
FIIs % 10.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 63.7 31.2%  
Shareholders   109,995 12,705 865.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   J.B.CHEMICALS  SUVEN LIFE SCIENCES  CIPLA  CADILA HEALTHCARE  VENUS REMEDIES  

Compare BIOCON With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Falls Over 750 Points from Day's High; Metal and Realty Stocks Witness Selling(Closing)

After opening the day on a strong note, Indian share markets witnessed a sharp sell-off during closing hours today and ended lower.

Related Views on News

BIOCON Announces Quarterly Results (2QFY21); Net Profit Down 23.9% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

NEULAND LABS 2019-20 Annual Report Analysis (Annual Result Update)

Sep 2, 2020 | Updated on Sep 2, 2020

Here's an analysis of the annual report of NEULAND LABS for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of NEULAND LABS. Also includes updates on the valuation of NEULAND LABS.

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, BIOCON has posted a net profit of Rs 3 bn (down 30.5% YoY). Sales on the other hand came in at Rs 16 bn (up 19.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (1QFY20); Net Profit Down 11.5% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, BIOCON has posted a net profit of Rs 1 bn (down 11.5% YoY). Sales on the other hand came in at Rs 5 bn (down 57.2% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

More Views on News

Most Popular

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Jan 21, 2021 03:30 PM

TRACK BIOCON

COMPARE BIOCON WITH

MARKET STATS